The Needle-Free Injection System Market report segments the market based on product, technology, type, site of delivery, applications, end user and regions. Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors. The jet-based needle-free injectors are expected to witness the highest growth during the forecast period, due to their advantages over the other injector systems.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861
What the Market Looks Like?
[238 Pages Report] The needle-free injection system market is projected to reach USD 272 million by 2026 from USD 124 million in 2021, at a CAGR of 17.0% from 2021 to 2026. North America is expected to dominate the market in 2016, with the U.S. accounting for a major share.
Jet-based needle-free injectors segment accounted for the largest share in the needle-free injection system market.
On the basis of technology, the needle-free injection system market can be segmented into jet-based, spring-based, microarray patches and other injectors. In 2020, the jet-based needle-free injectors segment is expected to command the largest share of 67.4% of the global needle-free injection system devices market by technology. This segment is projected to reach USD 196.9 million by 2026 from USD 71.4 million in 2020, at a CAGR of 18.3% during the forecast period. The large share of this segment can be attributed to benefits associated with this technology, including rapid drug administration, improved dosage accuracy, better diffusion into the tissue, and a faster response rate.
What are Key Trends in the Market?
The growth of the Needle-Free Injection System Market is primarily influenced by the following factors:
- Growing Prevalence of Chronic Diseases
- Increasing Incidence of Communicable Diseases Due to Needlestick Injuries
- Rise in Demand for Self-Injection Devices
Hospitals & clinics segment accounted for the largest share in the needle-free injection system market.
Based on end users, the needle-free injection market is segmented into hospitals & clinics, home care settings, research laboratories, pharmaceutical and biotechnology companies, and other end users. The hospitals & clinics segment accounted for the largest market share of 61.0% in 2020. Factors such as technological advancements and an increase in demand for vaccination are driving the growth of the hospitals & clinics segment.
Based on the Applications, the market is segmented into vaccine delivery, insulin delivery, Oncology, pain management and other applications; the vaccine delivery application segment is projected to be the fastest-growing segment during forecast period in 2016. The growth of this market primarily attributed to factors such as the rising incidence of chronic diseases, technological advancement, and growing preference for self-medication.
Read more about Fillable Needle-Free Injectors Market@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=165815861
North America is expected to dominate the market in 2016, with the U.S. accounting for a major share. However, Europe is expected to grow at the highest CAGR during the forecast period. The high growth in this market is attributed to the rising demand for biologics, growing prevalence of chronic diseases, technological advancements, mergers and acquisitions by major companies in the market, favorable reimbursement policies, increasing healthcare expenditure and regulatory approvals of new injection system are key factors driving the market growth in Europe.
Recent Developments:
- In December 2021, PharmaJet partner, Nykode Therapeutics announces phase 1/2 clinical trial with next-generation DNA-based COVID-19 vaccine candidates
- In August 2021, PharmaJet partner Zydus Cadila announced Emergency Use Authorization approval for world’s first plasmid DNA COVID-19 vaccine deliver via needle-free injection.
- In May 2021, Enesi pharma achieves key milestone in development of thermostable solid-dose live vaccines against Measles and Rubella and soon entering into clinical trials
Frequently Asked Questions (FAQ):
- Which are the top industry players in the needle-free injection system market?
- What are the top trends in the needle-free injection system market?
- Which region is dominating in the needle-free injection system market?
- Which is the leading technology type in the needle-free injection system market?
- Which is the leading end user of the needle-free injection system market?
